[Clinical effectiveness of newborn screening for inborn errors of metabolism. Part II: Methylmalonic acidemia, Propionic acidemia, Tyrosinemia type I]

Seoane Mato D, Cantero Muñoz P, Atienza Merino G
Record ID 32013000850
Authors' objectives: To assess the clinical effectiveness of newborn screening of the following diseases, i.e., methylmalonic acidemia, propionic acidemia and tyrosinaemia type 1.
Authors' recommendations: The evidence of the effectiveness of screening programmes of inborn errors of metabolism evaluated in this review is of low quality and is based on observational studies – fundamentally longitudinal or comparative case series and cross-sectional studies without a control group – with direct evidence being furnished in only some cases.
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Humans
  • Metabolism, Inborn Errors
  • Neonatal Screening
Organisation Name: Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
Contact Address: Conselleria de Sanidade, Xunta de Galicia, San Lazaro s/n 15781 Santiago de Compostela, Spain. Tel: 34 981 541831; Fax: 34 981 542854;
Contact Name: avalia-t@sergas.es
Contact Email: avalia-t@sergas.es
Copyright: Galician Agency for Health Technology Assessment (AVALIA-T)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.